Interaction between atazanavir and fosamprenavir in the treatment of HIV-infected patients

J Acquir Immune Defic Syndr. 2006 Jan 1;41(1):124-5. doi: 10.1097/01.qai.0000192003.00530.9c.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-HIV Agents / administration & dosage
  • Anti-HIV Agents / therapeutic use*
  • Antiretroviral Therapy, Highly Active*
  • Atazanavir Sulfate
  • Carbamates
  • Drug Administration Schedule
  • Drug Interactions
  • Furans
  • HIV Infections / drug therapy*
  • Humans
  • Oligopeptides / administration & dosage
  • Oligopeptides / therapeutic use*
  • Organophosphates / administration & dosage
  • Organophosphates / therapeutic use*
  • Pyridines / administration & dosage
  • Pyridines / therapeutic use*
  • Sulfonamides / administration & dosage
  • Sulfonamides / therapeutic use*
  • Treatment Failure
  • Viremia / prevention & control

Substances

  • Anti-HIV Agents
  • Carbamates
  • Furans
  • Oligopeptides
  • Organophosphates
  • Pyridines
  • Sulfonamides
  • Atazanavir Sulfate
  • amprenavir
  • fosamprenavir